Meaning and Disease Mechanism
Dengue shock syndrome is the most severe circulatory complication of dengue. It occurs when extensive plasma leakage from small blood vessels causes a critical reduction in circulating blood volume, leading to shock.
It is included within the modern category of severe dengue.
The condition develops because dengue infection can trigger an intense immune response that increases the permeability of capillaries. The fluid component of blood escapes into surrounding tissues, while blood cells remain within the circulation.
This produces:
- reduced circulating blood volume;
- increased concentration of blood cells;
- inadequate supply of oxygen to tissues;
- falling blood pressure;
- impaired functioning of vital organs.
Fluid may also accumulate in the abdominal cavity or around the lungs.
Dengue shock syndrome is not caused mainly by visible blood loss. Its central mechanism is plasma leakage, although severe bleeding may occur simultaneously.
Clinical Progression and Warning Signs
Dengue shock syndrome usually develops during the critical phase, often when the fever begins to fall. This commonly occurs between the third and seventh day of illness.
A decline in temperature must therefore not automatically be interpreted as recovery.
Early warning signs include:
- severe abdominal pain;
- persistent vomiting;
- bleeding from the nose or gums;
- unusual drowsiness or restlessness;
- rapid breathing;
- fluid accumulation;
- enlarged liver;
- rapidly falling platelet count;
- rising haematocrit.
As shock develops, the patient may show:
- rapid and weak pulse;
- cold or pale extremities;
- clammy skin;
- delayed capillary refill;
- narrowing of pulse pressure;
- reduced urine output;
- dizziness or fainting;
- confusion or altered consciousness.
In the early stage, the systolic blood pressure may remain apparently normal while the difference between systolic and diastolic pressure becomes very small. This is called narrow pulse pressure and may be an important early sign of compensated shock.
If treatment is delayed, the condition can progress to severe hypotension, organ failure and irreversible shock.
Diagnosis and Assessment
Diagnosis is based on evidence of dengue infection together with circulatory failure caused by plasma leakage.
Important clinical and laboratory findings include:
- rapid pulse with weak peripheral circulation;
- narrow pulse pressure or low blood pressure;
- rising haematocrit;
- falling platelet count;
- reduced urine output;
- fluid around the lungs or inside the abdomen;
- signs of impaired liver, kidney, heart or brain function.
A rising haematocrit generally suggests that plasma is leaking while blood cells remain concentrated inside the circulation.
However, a falling haematocrit in an unstable patient may indicate significant internal bleeding rather than improvement. Laboratory values must therefore be interpreted together with the patient’s circulation and overall clinical condition.
Ultrasound or chest imaging may be used to detect:
- pleural effusion;
- ascites;
- gallbladder-wall swelling;
- other signs of plasma leakage.
Regular monitoring of pulse, blood pressure, breathing, urine output, haematocrit and mental status is essential.
Treatment and Monitoring
Dengue shock syndrome is a medical emergency requiring immediate hospital treatment.
The principal treatment is carefully controlled intravenous fluid replacement to restore circulation and oxygen delivery to tissues.
Management may include:
- rapid assessment of airway, breathing and circulation;
- isotonic intravenous fluids;
- repeated evaluation of pulse and blood pressure;
- close monitoring of urine output;
- serial measurement of haematocrit;
- oxygen support;
- blood transfusion in cases of significant bleeding;
- intensive-care support when organ failure develops.
Fluid therapy must be precise. Insufficient fluid may allow shock to worsen, while excessive fluid can cause pulmonary oedema and respiratory distress.
This risk becomes particularly important during the recovery phase, when leaked plasma begins returning to the bloodstream.
Platelet transfusion is not routinely required only because the platelet count is low. It is considered mainly when clinically significant bleeding or another clear medical indication is present.
Medicines such as aspirin and ibuprofen should generally be avoided because they may increase bleeding risk. Paracetamol may be used for fever and pain under appropriate medical guidance.
Early recognition and correctly managed fluid therapy can significantly reduce mortality.
Prevention and Public-Health Importance
Preventing dengue shock syndrome depends on both preventing dengue infection and identifying severe disease before shock develops.
Important preventive measures include:
- eliminating mosquito-breeding sites;
- covering water-storage containers;
- regularly emptying coolers, pots and discarded containers;
- using mosquito repellents and protective clothing;
- ensuring early medical evaluation of suspected dengue;
- monitoring patients closely when fever begins to decline;
- educating families about warning signs.
Patients with dengue should seek urgent medical care if they develop persistent vomiting, severe abdominal pain, bleeding, breathing difficulty, unusual weakness, reduced urination or altered behaviour.
Vaccination may reduce dengue burden in selected populations, but it does not provide complete protection and cannot replace mosquito control or clinical surveillance.
Conclusion
Dengue shock syndrome is a life-threatening form of severe dengue caused mainly by extensive plasma leakage and circulatory failure. Its most dangerous feature is that it may begin when the fever appears to improve. Timely recognition of warning signs, careful monitoring and scientifically controlled fluid therapy are therefore essential for preventing organ failure and death.
